Muscarinic receptors on airway mesenchymal cells: Novel findings for an ancient target

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 1, 2013, Pages 145-155

  Meurs, Herman ^a,b   Dekkers, Bart G J ^a,b   Maarsingh, Harm ^a,b   Halayko, Andrew J ^c   Zaagsma, Johan ^a,b   Gosens, Reinoud ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Acetylcholine; Airway obstruction; Airway remodeling; Airway smooth muscle; Asthma; COPD; Fibroblast; Inflammation

Indexed keywords

ACETYLCHOLINE; ADENYLATE CYCLASE; ALPHA SMOOTH MUSCLE ACTIN; ATROPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; IPRATROPIUM BROMIDE; MAJOR BASIC PROTEIN; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; PHOSPHODIESTERASE IV; PROTEIN KINASE C; TIOTROPIUM BROMIDE; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TUMOR NECROSIS FACTOR ALPHA;

ACETYLCHOLINE RELEASE; AIRWAY; AIRWAY REMODELING; ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHOSPASM; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPETITIVE INHIBITION; DOWN REGULATION; ENDOPLASMIC RETICULUM; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; INFLAMMATORY CELL; LUNG ALVEOLUS MACROPHAGE; MESENCHYME CELL; MUSCLE CONTRACTION; MUSCLE GROWTH; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; VAGUS NERVE;

ACETYLCHOLINE; AIRWAY REMODELING; ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; FIBROBLASTS; HUMANS; INFLAMMATION; MOLECULAR TARGETED THERAPY; MUSCLE CONTRACTION; MYOCYTES, SMOOTH MUSCLE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, MUSCARINIC;

EID: 84873170983     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2012.07.003     Document Type: Article

References (208)

1. Jackson M. " Divine stramonium": the rise and fall of smoking for asthma. Med Hist 2010, 54:171-194.
2. Chapman K.R. The role of anticholinergics in asthma and COPD. Muscarinic receptors in airways diseases 2001, 203-219. Birkhäuser Verlag, Basel. J. Zaagsma, H. Meurs, A.F. Roffel (Eds.).
3. Salter H.H. On asthma: its pathology and treatment 1860, John Churchill and Sons, London, p. 161-204.
4. Fothergill J.M. Chronic bronchitis: its form and treatment 1882, Bailleire Tindal & Co, London.
5. Waters A.T.M. Researches on the nature, pathology and treatment of emphysema of the lungs 1862, Churchill, London.
6. Wiebe T.H., Sigurdson E.S., Katz L.Y. Angel's trumpet (Datura stramonium) poisoning and delirium in adolescents in Winnipeg, Manitoba: Summer 2006. Paediatr Child Health 2008, 13:193-196.
7. Global Initiative for Asthma Global strategy for asthma management and prevention December 2011.
8. Global Initiative for Chronic Obstructive Lung Disease Global strategy for diagnosis, management, and prevention of COPD December 2011.
9. Gross N.J. COPD: a disease of reversible air-flow obstruction. Am Rev Respir Dis 1986, 133:725-726.
10. Lanes S.F., Garrett J.E., Wentworth C.E., Fitzgerald J.M., Karpel J.P. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials. Chest 1998, 114:365-372.
11. Rodrigo G., Rodrigo C., Burschtin O. A meta-analysis of the effects of ipratropium bromide in adults with acute asthma. Am J Med 1999, 107:363-370.
12. Rodrigo G.J., Castro-Rodriguez J.A. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 2005, 60:740-746.
13. Anzueto A., Tashkin D., Menjoge S., Kesten S. One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. Pulm Pharmacol Ther 2005, 18:75-81.
14. Tashkin D.P., Celli B., Senn S., Burkhart D., Kesten S., Menjoge S., et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008, 359:1543-1554.
15. Decramer M., Celli B., Kesten S., Lystig T., Mehra S., Tashkin D.P. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet 2009, 374:1171-1178.
16. Morice A.H., Celli B., Kesten S., Lystig T., Tashkin D., Decramer M. COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT). Respir Med 2010, 104:1659-1667.
17. Bateman E.D., Rennard S., Barnes P.J., Dicpinigaitis P.V., Gosens R., Gross N.J., et al. Alternative mechanisms for tiotropium. Pulm Pharmacol Ther 2009, 22:533-542.
18. Gosens R., Zaagsma J., Meurs H., Halayko A.J. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res 2006, 7:73.
19. Kistemaker LE, Oenema TA, Meurs H, Gosens R. Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD. Life Sci, doi:10.1016/j.lfs.2012.02.021.
20. Wessler I., Kirkpatrick C.J. Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol 2008, 154:1558-1571.
21. Halayko A.J., Tran T., Ji S.Y., Yamasaki A., Gosens R. Airway smooth muscle phenotype and function: interactions with current asthma therapies. Curr Drug Targets 2006, 7:525-540.
22. Dekkers B.G.J., Maarsingh H., Meurs H., Gosens R. Airway structural components drive airway smooth muscle remodeling in asthma. Proc Am Thorac Soc 2009, 6:683-692.
23. Meurs H., Gosens R., Zaagsma J. Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models. Eur Respir J 2008, 32:487-502.
24. Postma D.S., Timens W. Remodeling in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006, 3:434-439.
25. Cockcroft D.W., Davis B.E. Mechanisms of airway hyperresponsiveness. J Allergy Clin Immunol 2006, 118:551-559.
26. Matthiesen S., Bahulayan A., Kempkens S., Haag S., Fuhrmann M., Stichnote C., et al. Muscarinic receptors mediate stimulation of human lung fibroblast proliferation. Am J Respir Cell Mol Biol 2006, 35:621-627.
27. Haag S., Matthiesen S., Juergens U.R., Racké K. Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts. Eur Respir J 2008, 32:555-562.
28. Canning B.J. Reflex regulation of airway smooth muscle tone. J Appl Physiol 2006, 101:971-985.
29. Einthoven W. über die Wirkung der Bronchialmuskeln, nach einer neuen Methode untersucht, und über Asthma nervosum. Pflügers Arch 1892, 51:367-444.
30. Zaagsma J., Roffel A.F., Meurs H. Muscarinic control of airway function. Life Sci 1997, 60:1061-1068.
31. Racké K., Matthiesen S. The airway cholinergic system: physiology and pharmacology. Pulm Pharmacol Ther 2004, 17:181-198.
32. Undem B.J., Kollarik M. The role of vagal afferent nerves in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005, 2:355-360.
33. Undem B.J., Carr M.J. Pharmacology of airway afferent nerve activity. Respir Res 2001, 2:234-244.
34. Myers A.C. Transmission in autonomic ganglia. Respir Physiol 2001, 125:99-111.
35. Gleich G.J., Flavahan N.A., Fujisawa T., Vanhoutte P.M. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J Allergy Clin Immunol 1988, 81:776-781.
36. Belmonte K.E. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005, 2:297-304.
37. 2 receptors after the early allergic reaction: possible contribution to bronchial hyperresponsiveness in allergic guinea-pigs. Br J Pharmacol 1995, 114:881-887.
38. 2 autoreceptors in vagally induced bronchoconstriction of conscious guinea pigs after the early allergic reaction. Eur J Pharmacol 1996, 318:131-139.
39. 2 muscarinic receptors in antigen-challenged guinea pigs. Br J Pharmacol 2009, 156:201-210.
40. Minette P.A., Lammers J.W., Dixon C.M., McCusker M.T., Barnes P.J. A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects. J Appl Physiol 1989, 67:2461-2465.
41. 2 muscarinic receptors in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 163:1320-1325.
42. Yu D.Y., Galant S.P., Gold W.M. Inhibition of antigen-induced bronchoconstriction by atropine in asthmatic patients. J Appl Physiol 1972, 32:823-828.
43. Fish J.E., Rosenthal R.R., Summer W.R., Menkes H., Norman P.S., Permutt S. The effect of atropine on acute antigen-mediated airway constriction in subjects with allergic asthma. Am Rev Respir Dis 1977, 115:371-379.
44. Cockcroft D.W., Ruffin R.E., Hargreave F.E. Effect of Sch1000 in allergen-induced asthma. Clin Allergy 1978, 8:361-372.
45. Buels K.S., Jacoby D.B., Fryer A.D. Non-bronchodilating mechanisms of tiotropium prevent airway hyperreactivity in a guinea-pig model of allergic asthma. Br J Pharmacol 2012, 165:1501-1514.
46. Raemdonck K., de A.J., Birrell M.A., Grace M., Maher S.A., Irvin C.G., et al. A role for sensory nerves in the late asthmatic response. Thorax 2012, 67:19-25.
47. Ewins A.J. Acetylcholine, a new active principle of Ergot. Biochem J 1914, 8:44-49.
48. Dale H.H., Dudley H.W. The presence of histamine and acetylcholine in the spleen of the ox and the horse. J Physiol 1929, 68:97-123.
49. Sastry B.V., Sadavongvivad C. Cholinergic systems in non-nervous tissues. Pharmacol Rev 1978, 30:65-132.
50. Wessler I., Kirkpatrick C.J., Racké K. The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans. Clin Exp Pharmacol Physiol 1999, 26:198-205.
51. Reinheimer T., Bernedo P., Klapproth H., Oelert H., Zeiske B., Racké K., et al. Acetylcholine in isolated airways of rat, guinea pig, and human: species differences in role of airway mucosa. Am J Physiol 1996, 270:L722-L728.
52. Klapproth H., Reinheimer T., Metzen J., Munch M., Bittinger F., Kirkpatrick C.J., et al. Non-neuronal acetylcholine, a signalling molecule synthezised by surface cells of rat and man. Naunyn Schmiedebergs Arch Pharmacol 1997, 355:515-523.
53. Proskocil B.J., Sekhon H.S., Jia Y., Savchenko V., Blakely R.D., Lindstrom J., et al. Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Endocrinology 2004, 145:2498-2506.
54. Kummer W., Lips K.S., Pfeil U. The epithelial cholinergic system of the airways. Histochem Cell Biol 2008, 130:219-234.
55. Lips K.S., Volk C., Schmitt B.M., Pfeil U., Arndt P., Miska D., et al. Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium. Am J Respir Cell Mol Biol 2005, 33:79-88.
56. Moffatt J.D., Cocks T.M., Page C.P. Role of the epithelium and acetylcholine in mediating the contraction to 5-hydroxytryptamine in the mouse isolated trachea. Br J Pharmacol 2004, 141:1159-1166.
57. Kummer W., Wiegand S., Akinci S., Schinkel A.H., Wess J., Koepsell H., et al. Role of acetylcholine and muscarinic receptors in serotonin-induced bronchoconstriction in the mouse. J Mol Neurosci 2006, 30:67-68.
58. Kummer W., Wiegand S., Akinci S., Wessler I., Schinkel A.H., Wess J., et al. Role of acetylcholine and polyspecific cation transporters in serotonin-induced bronchoconstriction in the mouse. Respir Res 2006, 7:65.
59. Roffel A.F., Meurs H., Zaagsma J. Identification, localization and function of muscarinic receptor subtypes in the airways. Muscarinic receptors in airways diseases 2001, 63-85. Birkhäuser Verlag, Basel. J. Zaagsma, H. Meurs, A.F. Roffel (Eds.).
60. 2 receptors in bovine tracheal smooth muscle: discrepancies between binding and function. Eur J Pharmacol 1988, 153:73-82.
61. 3 receptors mediate contraction of human central and peripheral airway smooth muscle. Pulm Pharmacol 1990, 3:47-51.
62. 3 muscarinic acetylcholine receptors. FASEB J 2004, 18:711-713.
63. 3-receptor knockout mice: muscarinic receptor function in atria, stomach fundus, urinary bladder, and trachea. Am J Physiol Regul Integr Comp Physiol 2002, 282:R1443-R1449.
64. 2 receptors in acetylcholine-isoproterenol functional antagonism in human isolated bronchus. Am J Physiol Lung Cell Mol Physiol 2002, 283:L1125-L1132.
65. Takuwa Y., Takuwa N., Rasmussen H. Carbachol induces a rapid and sustained hydrolysis of polyphosphoinositide in bovine tracheal smooth muscle measurements of the mass of polyphosphoinositides, 1,2-diacylglycerol, and phosphatidic acid. J Biol Chem 1986, 261:14670-14675.
66. Meurs H., Roffel A.F., Postema J.B., Timmermans A., Elzinga C.R.S., Kauffman H.F., et al. Evidence for a direct relationship between phosphoinositide metabolism and airway smooth muscle contraction induced by muscarinic agonists. Eur J Pharmacol 1988, 156:271-274.
67. Roffel A.F., Meurs H., Elzinga C.R.S., Zaagsma J. Characterization of the muscarinic receptor subtype involved in phosphoinositide metabolism in bovine tracheal smooth muscle. Br J Pharmacol 1990, 99:293-296.
68. Meurs H., Timmermans A., Van Amsterdam R.G.M., Brouwer F., Kauffman H.F., Zaagsma J. Muscarinic receptors in human airway smooth muscle are coupled to phosphoinositide metabolism. Eur J Pharmacol 1989, 164:369-371.
69. Yang C.M., Chou S.P., Sung T.C. Muscarinic receptor subtypes coupled to generation of different second messengers in isolated tracheal smooth muscle cells. Br J Pharmacol 1991, 104:613-618.
70. Hashimoto T., Hirata M., Ito Y. A role for inositol 1,4,5-trisphosphate in the initiation of agonist-induced contractions of dog tracheal smooth muscle. Br J Pharmacol 1985, 86:191-199.
71. 3 muscarinic receptors. Br J Pharmacol 1993, 110:983-988.
72. De Lanerolle P., Paul R.J. Myosin phosphorylation/dephosphorylation and regulation of airway smooth muscle contractility. Am J Physiol 1991, 261:L1-14.
73. Peel S.E., Liu B., Hall I.P. ORAI and store-operated calcium influx in human airway smooth muscle cells. Am J Respir Cell Mol Biol 2008, 38:744-749.
74. Jude J.A., Wylam M.E., Walseth T.F., Kannan M.S. Calcium signaling in airway smooth muscle. Proc Am Thorac Soc 2008, 5:15-22.
75. Xiao J.H., Zheng Y.M., Liao B., Wang Y.X. Functional role of canonical transient receptor potential 1 and canonical transient receptor potential 3 in normal and asthmatic airway smooth muscle cells. Am J Respir Cell Mol Biol 2010, 43:17-25.
76. Potier M., Trebak M. New developments in the signaling mechanisms of the store-operated calcium entry pathway. Pflugers Arch 2008, 457:405-415.
77. Dietrich A., Chubanov V., Kalwa H., Rost B.R., Gudermann T. Cation channels of the transient receptor potential superfamily: their role in physiological and pathophysiological processes of smooth muscle cells. Pharmacol Ther 2006, 112:744-760.
78. Higashida H., Yokoyama S., Hashii M., Taketo M., Higashida M., Takayasu T., et al. Muscarinic receptor-mediated dual regulation of ADP-ribosyl cyclase in NG108-15 neuronal cell membranes. J Biol Chem 1997, 272:31272-31277.
79. White T.A., Kannan M.S., Walseth T.F. Intracellular calcium signaling through the cADPR pathway is agonist specific in porcine airway smooth muscle. FASEB J 2003, 17:482-484.
80. Deshpande D.A., White T.A., Dogan S., Walseth T.F., Panettieri R.A., Kannan M.S. CD38/cyclic ADP-ribose signaling: role in the regulation of calcium homeostasis in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2005, 288:L773-L788.
81. 2+ signalling by protein kinase C in airway smooth muscle cells. Eur J Pharmacol 1995, 290:R5-R7.
82. Rossetti M., Savineau J.P., Crevel H., Marthan R. Role of protein kinase C in nonsensitized and passively sensitized human isolated bronchial smooth muscle. Am J Physiol 1995, 268:L966-L971.
83. + transport. Eur J Pharmacol 1996, 315:65-71.
84. 2: probing the complexities of the calcium network. Cell Calcium 2009, 45:535-545.
85. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003, 83:1325-1358.
86. Schaafsma D., Boterman M., de Jong A.M., Hovens I., Penninks J.M., Nelemans S.A., et al. Differential Rho-kinase dependency of full and partial muscarinic receptor agonists in airway smooth muscle contraction. Br J Pharmacol 2006, 147:737-743.
87. Gosens R., Schaafsma D., Nelemans S.A., Halayko A.J. Rho-kinase as a drug target for the treatment of airway hyperresponsiveness in asthma. Mini Rev Med Chem 2006, 6:339-348.
88. q/11-coupled receptor signaling and RhoA. J Biol Chem 2005, 280:11134-11139.
89. Schaafsma D., Gosens R., Zaagsma J., Halayko A.J., Meurs H. Rho kinase inhibitors: a novel therapeutical intervention in asthma?. Eur J Pharmacol 2008, 585:398-406.
90. Ma X., Cheng Z., Kong H., Wang Y., Unruh H., Stephens N.L., et al. Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects. Am J Physiol Lung Cell Mol Physiol 2002, 283:L1181-L1189.
91. de Jongste J.C., Mons H., Bonta I.L., Kerrebijn K.F. In vitro responses of airways from an asthmatic patient. Eur J Respir Dis 1987, 71:23-29.
92. Opazo Saez A.M., Seow C.Y., Pare P.D. Peripheral airway smooth muscle mechanics in obstructive airways disease. Am J Respir Crit Care Med 2000, 161:910-917.
93. Bai T.R. Abnormalities in airway smooth muscle in fatal asthma. Am Rev Respir Dis 1990, 141:552-557.
94. Hakonarson H., Herrick D.J., Serrano P.G., Grunstein M.M. Mechanism of cytokine-induced modulation of β-adrenoceptor responsiveness in airway smooth muscle. J Clin Invest 1996, 97:2593-2600.
95. qα protein expression and function in human airway smooth muscle cells. Am J Physiol 1999, 276:L405-L411.
96. Deshpande D.A., Dogan S., Walseth T.F., Miller S.M., Amrani Y., Panettieri R.A., et al. Modulation of calcium signaling by interleukin-13 in human airway smooth muscle: role of CD38/cyclic adenosine diphosphate ribose pathway. Am J Respir Cell Mol Biol 2004, 31:36-42.
97. Tliba O., Panettieri R.A., Tliba S., Walseth T.F., Amrani Y. Tumor necrosis factor-α differentially regulates the expression of proinflammatory genes in human airway smooth muscle cells by activation of interferon-β-dependent CD38 pathway. Mol Pharmacol 2004, 66:322-329.
98. 2+ signaling contributes to airway smooth muscle hyperresponsiveness. FASEB J 2003, 17:452-454.
99. Jude J.A., Solway J., Panettieri R.A., Walseth T.F., Kannan M.S. Differential induction of CD38 expression by TNF-α in asthmatic airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2010, 299:L879-L890.
100. White T.A., Xue A., Chini E.N., Thompson M., Sieck G.C., Wylam M.E. Role of transient receptor potential C3 in TNF-α-enhanced calcium influx in human airway myocytes. Am J Respir Cell Mol Biol 2006, 35:243-251.
101. Schaafsma D., Gosens R., Bos I.S.T., Meurs H., Zaagsma J., Nelemans S.A. Allergic sensitization enhances the contribution of Rho-kinase to airway smooth muscle contraction. Br J Pharmacol 2004, 143:477-484.
102. 2+ sensitization of bronchial smooth muscle contraction in antigen-induced airway hyperresponsive rats. Br J Pharmacol 1999, 127:597-600.
103. Schaafsma D., Bos I.S.T., Zuidhof A.B., Zaagsma J., Meurs H. Inhalation of the Rho-kinase inhibitor Y-27632 reverses allergen-induced airway hyperresponsiveness after the early and late asthmatic reaction. Respir Res 2006, 7:121.
104. Schaafsma D., Zuidhof A.B., Nelemans S.A., Zaagsma J., Meurs H. Inhibition of Rho-kinase normalizes nonspecific hyperresponsiveness in passively sensitized airway smooth muscle preparations. Eur J Pharmacol 2006, 531:145-150.
105. Schaafsma D., Bos I.S.T., Zuidhof A.B., Zaagsma J., Meurs H. The inhaled rho kinase inhibitor Y-27632 protects against allergen-induced acute bronchoconstriction, airway hyperresponsiveness, and inflammation. Am J Physiol Lung Cell Mol Physiol 2008, 295:L214-L219.
106. Henry P.J., Mann T.S., Goldie R.G. A rho kinase inhibitor, Y-27632 inhibits pulmonary eosinophilia, bronchoconstriction and airways hyperresponsiveness in allergic mice. Pulm Pharmacol Ther 2005, 18:67-74.
107. Chiba Y., Matsusue K., Misawa M. RhoA, a possible target for treatment of airway hyperresponsiveness in bronchial asthma. J Pharmacol Sci 2010, 114:239-247.
108. Chiba Y., Nakazawa S., Todoroki M., Shinozaki K., Sakai H., Misawa M. Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein. Am J Respir Cell Mol Biol 2009, 40:159-167.
109. Sakai H., Otogoto S., Chiba Y., Abe K., Misawa M. Involvement of p42/44 MAPK and RhoA protein in augmentation of ACh-induced bronchial smooth muscle contraction by TNF-alpha in rats. J Appl Physiol 2004, 97:2154-2159.
110. Goto K., Chiba Y., Matsusue K., Hattori Y., Maitani Y., Sakai H., et al. The proximal STAT6 and NF-κB sites are responsible for IL-13- and TNF-α-induced RhoA transcriptions in human bronchial smooth muscle cells. Pharmacol Res 2010, 61:466-472.
111. Morin C., Sirois M., Echave V., Rousseau E. CPI-17 silencing-reduced responsiveness in control and TNF-α-treated human bronchi. Am J Respir Cell Mol Biol 2008, 39:638-643.
112. Sakai H., Chiba Y., Hirano T., Misawa M. Possible involvement of CPI-17 in augmented bronchial smooth muscle contraction in antigen-induced airway hyperresponsive rats. Mol Pharmacol 2005, 68:145-151.
113. 2+ reuptake in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2009, 297:L26-L34.
114. 2+ ATPase (SERCA) expression contributes to airway remodelling in bronchial asthma. Proc Natl Acad Sci U S A 2009, 106:10775-10780.
115. Halayko A.J., Solway J. Molecular mechanisms of phenotypic plasticity in smooth muscle cells. J Appl Physiol 2001, 90:358-368.
116. Halayko A.J., Tran T., Gosens R. Phenotype and functional plasticity of airway smooth muscle: role of caveolae and caveolins. Proc Am Thorac Soc 2008, 5:80-88.
117. Oenema TA, Smit M, Smedinga L, Racké K, Halayko AJ, Meurs H, Gosens R. Muscarinic receptor stimulation augments TGF-β1-induced contractile protein expression by airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol, in press.
118. Goldsmith A.M., Bentley J.K., Zhou L., Jia Y., Bitar K.N., Fingar D.C., et al. Transforming growth factor-β induces airway smooth muscle hypertrophy. Am J Respir Cell Mol Biol 2006, 34:247-254.
119. Morishima Y., Nomura A., Uchida Y., Noguchi Y., Sakamoto T., Ishii Y., et al. Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding. Am J Respir Cell Mol Biol 2001, 24:1-11.
120. Tran T., McNeill K.D., Gerthoffer W.T., Unruh H., Halayko A.J. Endogenous laminin is required for human airway smooth muscle cell maturation. Respir Res 2006, 7:117.
121. Dekkers B.G.J., Schaafsma D., Nelemans S.A., Zaagsma J., Meurs H. Extracellular matrix proteins differentially regulate airway smooth muscle phenotype and function. Am J Physiol Lung Cell Mol Physiol 2007, 292:L1405-L1413.
122. Dekkers B.G.J., Schaafsma D., Tran T., Zaagsma J., Meurs H. Insulin-induced laminin expression promotes a hypercontractile airway smooth muscle phenotype. Am J Respir Cell Mol Biol 2009, 41:494-504.
123. Halayko A.J., Kartha S., Stelmack G.L., McConville J., Tam J., Camoretti-Mercado B., et al. Phophatidylinositol-3 kinase/mammalian target of rapamycin/p70S6K regulates contractile protein accumulation in airway myocyte differentiation. Am J Respir Cell Mol Biol 2004, 31:266-275.
124. Liu H.W., Halayko A.J., Fernandes D.J., Harmon G.S., McCauley J.A., Kocieniewski P., et al. The rhoA/rho kinase pathway regulates nuclear localization of serum response factor. Am J Respir Cell Mol Biol 2003, 29:39-47.
125. Schaafsma D., McNeill K.D., Stelmack G.L., Gosens R., Baarsma H.A., Dekkers B.G.J., et al. Insulin increases the expression of contractile phenotypic markers in airway smooth muscle. Am J Physiol Cell Physiol 2007, 293:C429-C439.
126. Gosens R., Schaafsma D., Meurs H., Zaagsma J., Nelemans S.A. Role of rho-kinase in maintaining airway smooth muscle contractile phenotype. Eur J Pharmacol 2004, 483:71-78.
127. Krymskaya V.P., Orsini M.J., Eszterhas A.J., Brodbeck K.C., Benovic J.L., Panettieri R.A., et al. Mechanisms of proliferation synergy by receptor tyrosine kinase and G protein-coupled receptor activation in human airway smooth muscle. Am J Respir Cell Mol Biol 2000, 23:546-554.
128. Gosens R., Mutawe M., Martin S., Basu S., Bos I.S.T., Tran T., et al. Caveolae and caveolins in the respiratory system. Curr Mol Med 2008, 8:741-753.
129. Gosens R., Stelmack G.L., Dueck G., McNeill K.D., Yamasaki A., Gerthoffer W.T., et al. Role of caveolin-1 in p42/p44 MAP kinase activation and proliferation of human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2006, 291:L523-L534.
130. Gosens R., Dueck G., Gerthoffer W.T., Unruh H., Zaagsma J., Meurs H., et al. p42/p44 MAP kinase activation is localized to caveolae-free membrane domains in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2007, 292:L1163-L1172.
131. Prakash Y.S., Thompson M.A., Vaa B., Matabdin I., Peterson T.E., He T., et al. Caveolins and intracellular calcium regulation in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2007, 293:L1118-L1126.
132. 2+ mobilization and contraction in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2007, 293:L1406-L1418.
133. Schlenz H., Kummer W., Jositsch G., Wess J., Krasteva G. Muscarinic receptor-mediated bronchoconstriction is coupled to caveolae in murine airways. Am J Physiol Lung Cell Mol Physiol 2010, 298:L626-L636.
134. 2+ in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2011, 301:L607-L614.
135. Gosens R., Stelmack G.L., Bos S.T., Dueck G., Mutawe M.M., Schaafsma D., et al. Caveolin-1 is required for contractile phenotype expression by airway smooth muscle cells. J Cell Mol Med 2011, 15:2430-2442.
136. Sankary R.M., Jones C.A., Madison J.M., Brown J.K. Muscarinic cholinergic inhibition of cyclic AMP accumulation in airway smooth muscle. Role of a pertussis toxin-sensitive protein. Am Rev Respir Dis 1988, 138:145-150.
137. Ca channels in smooth muscle cells by a pertussis-sensitive G protein. Am J Physiol 1991, 261:C1204-C1209.
138. + channel activity. J Biol Chem 2008, 283:21036-21044.
139. 2 muscarinic receptors inhibit isoproterenol-induced relaxation of canine airway smooth muscle. J Pharmacol Exp Ther 1992, 262:119-126.
140. 3 receptor stimulation and antagonism on responses to isoprenaline of guinea-pig trachea in vitro. Br J Pharmacol 1994, 112:179-187.
141. 2 receptors do not participate in the functional antagonism between methacholine and isoprenaline in guinea pig tracheal smooth muscle. Eur J Pharmacol 1993, 249:235-238.
142. 2 receptors in functional antagonism in bovine trachea. Br J Pharmacol 1995, 115:665-671.
143. Watson N., Magnussen H., Rabe K.F. Antagonism of β-adrenoceptor-mediated relaxations of human bronchial smooth muscle by carbachol. Eur J Pharmacol 1995, 275:307-310.
144. Van Amsterdam R.G., Meurs H., Ten Berge R.E., Veninga N.C., Brouwer F., Zaagsma J. Role of phosphoinositide metabolism in human bronchial smooth muscle contraction and in functional antagonism by β-adrenoceptor agonists. Am Rev Respir Dis 1990, 142:1124-1128.
145. s pathways in airway smooth muscle regulates bronchial contractility and relaxation. J Clin Invest 2007, 117:1391-1398.
146. Nino G., Hu A., Grunstein J.S., McDonough J., Kreiger P.A., Josephson M.B., et al. G protein βγ-subunit signaling mediates airway hyperresponsiveness and inflammation in allergic asthma. PLoS One 2012, 7:e32078.
147. Meurs H., Roffel A.F., Elzinga C.R.S., Zaagsma J. Muscarinic receptor-β-adrenoceptor cross-talk in airway smooth muscle. Muscarinic receptors in airways diseases 2001, 121-158. Birkhäuser Verlag, Basel. J. Zaagsma, H. Meurs, A.F. Roffel (Eds.).
148. van Amsterdam R.G.M., Meurs H., Brouwer F., Postema J.B., Timmermans A., Zaagsma J. Role of phosphoinositide metabolism in functional antagonism of airway smooth muscle contraction by β-adrenoceptor agonists. Eur J Pharmacol 1989, 172:175-183.
149. Grandordy B.M., Mak J.C., Barnes P.J. Modulation of airway smooth muscle β-adrenoceptor function by a muscarinic agonist. Life Sci 1994, 54:185-191.
150. Boterman M., Elzinga C.R.S., Wagemakers D., Eppens P.B., Zaagsma J., Meurs H. Potentiation of β-adrenoceptor function in bovine tracheal smooth muscle by inhibition of protein kinase C. Eur J Pharmacol 2005, 516:85-92.
151. Sibley D.R., Lefkowitz R.J. Molecular mechanisms of receptor desensitization using the β-adrenergic receptor-coupled adenylate cyclase system as a model. Nature 1985, 317:124-129.
152. Houslay M.D. 'Crosstalk': a pivotal role for protein kinase C in modulating relationships between signal transduction pathways. Eur J Biochem 1991, 195:9-27.
153. Pyne N.J., Freissmuth M., Palmer S. Phosphorylation of the spliced variant forms of the recombinant stimulatory guanine-nucleotide-binding regulatory protein (Gs alpha) by protein kinase C. Biochem J 1992, 285(Pt 1):333-338.
154. i). Br J Pharmacol 1992, 107:881-887.
155. 2-adrenoceptor in bovine tracheal smooth muscle. Eur J Pharmacol 2006, 529:151-156.
156. Chuang T.T., LeVine H., De B.A. Phosphorylation and activation of β-adrenergic receptor kinase by protein kinase C. J Biol Chem 1995, 270:18660-18665.
157. Chuang T.T., Iacovelli L., Sallese M., De B.A. G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications. Trends Pharmacol Sci 1996, 17:416-421.
158. 2-agonists and muscarinic antagonists in COPD. Pulm Pharmacol Ther 2010, 23:257-267.
159. Joos G.F. Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease. Expert Opin Investig Drugs 2010, 19:257-264.
160. Kerstjens H.A.M., Disse B., Schroder-Babo W., Bantje T.A., Gahlemann M., Sigmund R., et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J Allergy Clin Immunol 2011, 128:308-314.
161. van Noord J.A., Aumann J.L., Janssens E., Smeets J.J., Zaagsma J., Mueller A., et al. Combining tiotropium and salmeterol in COPD: effects on airflow obstruction and symptoms. Respir Med 2010, 104:995-1004.
162. van Noord J.A., Buhl R., Laforce C., Martin C., Jones F., Dolker M., et al. QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease. Thorax 2010, 65:1086-1091.
163. Smit M., Zuidhof A.B., Bos I.S.T., Maarsingh H., Gosens R., Zaagsma J., et al. The bronchoprotective effect of olodaterol against histamine is synergistically enhanced and prolonged by tiotropium. Am J Respir Crit Care Med 2011, 183:A1379.
164. Smit M., Zuidhof A.B., Bos I.S.T., Maarsingh H., Gosens R., Zaagsma J., et al. Acute reversal of allergen-induced airway hyperresponsiveness (AHR) by olodaterol is synergistically enhanced by tiotropium bromide. Eur Respir J 2011, 38(Suppl. 55):306S.
165. Postma D.S., Kerstjens H.A.M. Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 158:S187-S192.
166. Wessler I., Kilbinger H., Bittinger F., Unger R., Kirkpatrick C.J. The non-neuronal cholinergic system in humans: expression, function and pathophysiology. Life Sci 2003, 72:2055-2061.
167. Wollin L., Pieper M.P. Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD. Pulm Pharmacol Ther 2010, 23:345-354.
168. McQueen D.S., Donaldson K., Bond S.M., McNeilly J.D., Newman S., Barton N.J., et al. Bilateral vagotomy or atropine pre-treatment reduces experimental diesel-soot induced lung inflammation. Toxicol Appl Pharmacol 2007, 219:62-71.
169. Pera T., Zuidhof A., Valadas J., Smit M., Schoemaker R.G., Gosens R., et al. Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD. Eur Respir J 2011, 38:789-796.
170. Nishioka T., Ikeda M., Fukuchi K., Tishi T. A critical role of muscarinic receptors in bleomycin-induced lung inflammation and fibrosis. Am J Respir Crit Care Med 2009, 179:A3426.
171. Ohta S., Oda N., Yokoe T., Tanaka A., Yamamoto Y., Watanabe Y., et al. Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma. Clin Exp Allergy 2010, 40:1266-1275.
172. Damera G., Jiang M., Zhao H., Fogle H.W., Jester W.F., Freire J., et al. Aclidinium bromide abrogates allergen-induced hyperresponsiveness and reduces eosinophilia in murine model of airway inflammation. Eur J Pharmacol 2010, 649:349-353.
173. 3 muscarinic receptor antagonist bencycloquidium bromide attenuates allergic airway inflammation, hyperresponsiveness and remodeling in mice. Eur J Pharmacol 2011, 655:83-90.
174. Bos I.S.T., Gosens R., Zuidhof A.B., Schaafsma D., Halayko A.J., Meurs H., et al. Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur Respir J 2007, 30:653-661.
175. Cui Y., Devillier P., Kuang X., Wang H., Zhu L., Xu Z., et al. Tiotropium reduction of lung inflammation in a model of chronic gastro-oesophageal reflux. Eur Respir J 2010, 35:1370-1376.
176. Zhang W., Fievez L., Zhang F., Cheu E., Antoine N., Delguste C., et al. Effects of formoterol and ipratropium bromide on repeated cadmium inhalation-induced pulmonary inflammation and emphysema in rats. Eur J Pharmacol 2010, 647:178-187.
177. + peripheral blood T-cells apoptosis in COPD. Immunobiology 2012, 217:345-353.
178. Buhling F., Lieder N., Kuhlmann U.C., Waldburg N., Welte T. Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro. Respir Med 2007, 101:2386-2394.
179. Vacca G., Randerath W.J., Gillissen A. Inhibition of granulocyte migration by tiotropium bromide. Respir Res 2011, 12:24.
180. Koyama S., Rennard S.I., Robbins R.A. Acetylcholine stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. Am J Physiol 1992, 262:L466-L471.
181. Koyama S., Sato E., Nomura H., Kubo K., Nagai S., Izumi T. Acetylcholine and substance P stimulate bronchial epithelial cells to release eosinophil chemotactic activity. J Appl Physiol 1998, 84:1528-1534.
182. 3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells. Eur Respir J 2009, 34:1436-1443.
183. Profita M., Bonanno A., Siena L., Ferraro M., Montalbano A.M., Pompeo F., et al. Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFκ B/ERK-dependent mechanism. Eur J Pharmacol 2008, 582:145-153.
184. Profita M., Bonanno A., Montalbano A.M., Ferraro M., Siena L., Bruno A., et al. Cigarette smoke extract activates human bronchial epithelial cells affecting non-neuronal cholinergic system signalling in vitro. Life Sci 2011, 89:36-43.
185. Kolch W., Heidecker G., Kochs G., Hummel R., Vahidi H., Mischak H., et al. Protein kinase Cα activates RAF-1 by direct phosphorylation. Nature 1993, 364:249-252.
186. Trushin S.A., Pennington K.N., geciras-Schimnich A., Paya C.V. Protein kinase C and calcineurin synergize to activate Iκ B kinase and NF-κ B in T lymphocytes. J Biol Chem 1999, 274:22923-22931.
187. Oenema T.A., Kolahian S., Nanninga J.E., Rieks D., Hiemstra P.S., Zuyderduyn S., et al. Pro-inflammatory mechanisms of muscarinic receptor stimulation in airway smooth muscle. Respir Res 2010, 11:130.
188. Behzad A.R., McDonough J.E., Seyednejad N., Hogg J.C., Walker D.C. The disruption of the epithelial mesenchymal trophic unit in COPD. COPD 2009, 6:421-431.
189. Davies D.E. The role of the epithelium in airway remodeling in asthma. Proc Am Thorac Soc 2009, 6:678-682.
190. Gosens R., Bos I.S.T., Zaagsma J., Meurs H. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am J Respir Crit Care Med 2005, 171:1096-1102.
191. Arai N., Kondo M., Izumo T., Tamaoki J., Nagai A. Inhibition of neutrophil elastase-induced goblet cell metaplasia by tiotropium in mice. Eur Respir J 2010, 35:1164-1171.
192. Matthiesen S., Bahulayan A., Holz O., Racké K. MAPK pathway mediates muscarinic receptor-induced human lung fibroblast proliferation. Life Sci 2007, 80:2259-2262.
193. Pieper M.P., Chaudhary N.I., Park J.E. Acetylcholine-induced proliferation of fibroblasts and myofibroblasts in vitro is inhibited by tiotropium bromide. Life Sci 2007, 80:2270-2273.
194. Profita M., Bonanno A., Siena L., Bruno A., Ferraro M., Montalbano A.M., et al. Smoke, choline acetyltransferase, muscarinic receptors, and fibroblast proliferation in chronic obstructive pulmonary disease. J Pharmacol Exp Ther 2009, 329:753-763.
195. 3-receptors mediate cholinergic synergism of mitogenesis in airway smooth muscle. Am J Respir Cell Mol Biol 2003, 28:257-262.
196. Gosens R., Dueck G., Rector E., Nunes R.O., Gerthoffer W.T., Unruh H., et al. Cooperative regulation of GSK-3 by muscarinic and PDGF receptors is associated with airway myocyte proliferation. Am J Physiol Lung Cell Mol Physiol 2007, 293:L1348-L1358.
197. Billington C.K., Kong K.C., Bhattacharyya R., Wedegaertner P.B., Panettieri R.A., Chan T.O., et al. Cooperative regulation of p70S6 kinase by receptor tyrosine kinases and G protein-coupled receptors augments airway smooth muscle growth. Biochemistry 2005, 44:14595-14605.
198. q/11. FASEB J 2006, 20:1558-1560.
199. Milara J., Serrano A., Peiro T., Gavalda A., Miralpeix M., Morcillo E.J., et al. Aclidinium inhibits human lung fibroblast to myofibroblast transition. Thorax 2012, 67:229-237.
200. Wipff P.J., Rifkin D.B., Meister J.J., Hinz B. Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix. J Cell Biol 2007, 179:1311-1323.
201. Tatler A.L., John A.E., Jolly L., Habgood A., Porte J., Brightling C., et al. Integrin alphavbeta5-mediated TGF-β activation by airway smooth muscle cells in asthma. J Immunol 2011, 187:6094-6107.
202. Kanefsky J., Lenburg M., Hai C.M. Cholinergic receptor and cyclic stretch-mediated inflammatory gene expression in intact ASM. Am J Respir Cell Mol Biol 2006, 34:417-425.
203. Fairbank N.J., Connolly S.C., Mackinnon J.D., Wehry K., Deng L., Maksym G.N. Airway smooth muscle cell tone amplifies contractile function in the presence of chronic cyclic strain. Am J Physiol Lung Cell Mol Physiol 2008, 295:L479-L488.
204. Grainge C.L., Lau L.C., Ward J.A., Dulay V., Lahiff G., Wilson S., et al. Effect of bronchoconstriction on airway remodeling in asthma. N Engl J Med 2011, 364:2006-2015.
205. Oenema T.A., Smedinga L., Mensink G., Halayko A.J., Zaagsma J., Meurs H., et al. TGFβ1-induced extracellular matrix production enhances airway smooth muscle cell proliferation. Eur Respir J 2011, 38(Suppl. 55):121S.
206. Bateman E.D., Kornmann O., Schmidt P., Pivovarova A., Engel M., Fabbri L.M. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol 2011, 128:315-322.
207. Peters S.P., Kunselman S.J., Icitovic N., Moore W.C., Pascual R., Ameredes B.T., et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010, 363:1715-1726.
208. Penn R.B. Embracing emerging paradigms of G protein-coupled receptor agonism and signaling to address airway smooth muscle pathobiology in asthma. Naunyn Schmiedebergs Arch Pharmacol 2008, 378:149-169.